Unapproved New Drugs/Misbranded/Botox
Similar Posts
Catalent Indiana, LLC – 718189 – 11/20/2025
CGMP/Finished Pharmaceuticals/AdulteratedGDUFA Type II API DMF Payment Receipts Report
GDUFA Type II API DMF Payment Receipts ReportApollo Care LLC. Columbia, MO. 483 issued 03/27/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 03/27/2025
Short Title (70 char) Apollo Care LLC. Columbia, MO. 483 issued 03/27/2025
FEI Number 3013927023
Firm Name Apollo Care LLC
Record Type 483
State MO
Establishment Type Outsourcing FacilityHuman Drug Compounding
Compounded drugs can serve an important medical need for certain patients, they also present a risk to patients.Notable Approvals | Drugs
News about human drug-related approvalsFDA warns about rare occurrences of a serious infection of the genital area with SGLT2 inhibitors for diabetes
The U.S. Food and Drug Administration (FDA) is warning that cases of a rare but serious infection of the genitals and area around the genitals have been reported with the class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (SGLT2) inhibitors.